Skip to content

Study · Measured the body's own peptide · 2022

1 result

[Structural changes and functional evaluation of the thymus in aging mouse induced by D-galactose].

Huang R, Liang J, Luo C, Yang J, Chen H, Xie X

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology1 Oct 2022

PMID36163621 (opens in a new tab)PepBankPUB-36163621

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In mice with D-galactose induced thymus aging, the body's own plasma thymosin alpha‑1 was lower than in controls.

    In plain wordsIn mice with D-galactose induced thymus aging, the body's own thymosin alpha‑1 levels in blood were lower.

    Outcome
    DecreasePlasma thymosin alpha 1 in D-galactose aging mice
    Study

    mousen: not reported in source

    D-galactose induced thymus aging
    Comparator
    Control (saline)
    Outcome group
    Aging markers · Immune and inflammation

    Source sentences

    Summary
    decreased plasma thymosin α1
    2 context sentences
    Summary · context
    Female C57BL/6 mice were randomly divided into control group and [1000 mg/(kg.d )] D-galactose treatment group, with 24 mice in each group.
    Summary · context
    The contents of thymosin β4, thymosin α1, and thymopoietin in plasma were determined by ELISA.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    12 Oct 2026, 17:28 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.